Re­call re­port: Pfiz­er puts a stop on Chan­tix dis­tri­b­u­tion af­ter traces of pos­si­ble car­cino­gens found

Af­ter find­ing el­e­vat­ed lev­els of can­cer-caus­ing ni­trosamines, Pifz­er is halt­ing dis­tri­b­u­tion of its an­ti-smok­ing med Chan­tix and re­call­ing four lots of the drug.

This comes …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER